search
Back to results

Photodynamic Therapy During Supportive Periodontal Therapy

Primary Purpose

Periodontal Diseases, Chronic Periodontitis, Periodontal Attachment Loss

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Fotosan 630, CMS Dental, Copenhagen, Denmark
Scaling and root planing
Sponsored by
National University of Singapore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Periodontal Diseases focused on measuring drug therapy, Photosensitizing Agents, therapeutic use

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Good general health with no systemic diseases causing manifestation of periodontal diseases
  2. Age ≥ 21 years
  3. History of chronic periodontitis
  4. At least two residual PPD ≥ 5 mm with or without bleeding on probing
  5. Compliant with recalls, i.e. last SPT visit at most 6 months before start of trial
  6. Able to give written informed consent

Exclusion Criteria:

  1. Pregnant or lactating females
  2. Local or systemic antibiotics intake in the past 3 months
  3. Systemic conditions which could affect progression of periodontitis
  4. Long term use of NSAIDs or immunosuppressive medications
  5. Participation in other clinical trials

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Other

    Arm Label

    Photodynamic therapy protocol

    SRP

    Arm Description

    In addition to scaling and root debridement, test sites received PDT according to manufacturer's instructions.

    Scaling and root debridement of the residual pockets were performed using ultrasonic device and hand curettes until root surfaces felt hard and smooth. The sites were then polished using rubber cup and prophylaxis paste.

    Outcomes

    Primary Outcome Measures

    Difference in percentage change in probing pocket depth

    Secondary Outcome Measures

    Bleeding on probing
    Clinical attachment level
    Recession
    Cytokines level

    Full Information

    First Posted
    January 25, 2016
    Last Updated
    January 27, 2016
    Sponsor
    National University of Singapore
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02666573
    Brief Title
    Photodynamic Therapy During Supportive Periodontal Therapy
    Official Title
    Effects of Photodynamic Therapy on Clinical and Immunological Parameters in a Group of Periodontal Patients Undergoing Supportive Periodontal Therapy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    June 2013 (undefined)
    Primary Completion Date
    December 2014 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    National University of Singapore

    4. Oversight

    5. Study Description

    Brief Summary
    27 subjects on SPT, each with at least two residual pockets ≥5mm, were recruited for this randomised, split-mouth controlled trial, providing a total of 72 sites. At baseline, probing pocket depth (PPD), recession, clinical attachment level (CAL), plaque and bleeding on probing (BOP) of all sites were examined. Gingival crevicular fluid (GCF) were collected to determine level of cytokines IL-1β, -6, -8, TNF-α and MMP-8 via ELISA. Control sites received subgingival instrumentation and rubber cup polishing with pumice. In addition test sites received a single application of PDT using Fotosan® and photosensitizer consisting of toludine blue O solution. The subjects were recalled three and six months later and re-examined. Site level analysis was performed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Periodontal Diseases, Chronic Periodontitis, Periodontal Attachment Loss
    Keywords
    drug therapy, Photosensitizing Agents, therapeutic use

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Factorial Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    27 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Photodynamic therapy protocol
    Arm Type
    Experimental
    Arm Description
    In addition to scaling and root debridement, test sites received PDT according to manufacturer's instructions.
    Arm Title
    SRP
    Arm Type
    Other
    Arm Description
    Scaling and root debridement of the residual pockets were performed using ultrasonic device and hand curettes until root surfaces felt hard and smooth. The sites were then polished using rubber cup and prophylaxis paste.
    Intervention Type
    Device
    Intervention Name(s)
    Fotosan 630, CMS Dental, Copenhagen, Denmark
    Intervention Description
    The PDT system consists of a hand-held rechargeable light-emitting diode (LED) light source (Fotosan® 630 device, CMS Dental, Copenhagen, Denmark) and 0.1 mg/mL toluidine blue photosensitiser. The LED light source has a wavelength between 620 to 640 nm and peak of 630 nm and a power density between 2000 to 4000 mW/cm2.
    Intervention Type
    Other
    Intervention Name(s)
    Scaling and root planing
    Intervention Description
    Scaling and root debridement of the residual pockets were performed using ultrasonic device and hand curettes until root surfaces felt hard and smooth. The sites were then polished using rubber cup and prophylaxis paste.
    Primary Outcome Measure Information:
    Title
    Difference in percentage change in probing pocket depth
    Time Frame
    6 months
    Secondary Outcome Measure Information:
    Title
    Bleeding on probing
    Time Frame
    6 months
    Title
    Clinical attachment level
    Time Frame
    6 months
    Title
    Recession
    Time Frame
    6 months
    Title
    Cytokines level
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Good general health with no systemic diseases causing manifestation of periodontal diseases Age ≥ 21 years History of chronic periodontitis At least two residual PPD ≥ 5 mm with or without bleeding on probing Compliant with recalls, i.e. last SPT visit at most 6 months before start of trial Able to give written informed consent Exclusion Criteria: Pregnant or lactating females Local or systemic antibiotics intake in the past 3 months Systemic conditions which could affect progression of periodontitis Long term use of NSAIDs or immunosuppressive medications Participation in other clinical trials

    12. IPD Sharing Statement

    Learn more about this trial

    Photodynamic Therapy During Supportive Periodontal Therapy

    We'll reach out to this number within 24 hrs